7.0% CAGR Growth in Asia-Pacific Life Science Instrumentation Market Supported by Rising R&D

Asia-Pacific life science instrumentation market was valued at $14.1 billion in 2025 and is projected to reach $27.6 billion by 2035, growing at a CAGR of 7.0% during the forecast period (2026–2035). Research and development are an integral part of the science field to create a better healthcare system, and this factor is driving the demand for the advanced life science instrumentation market. Due to the lower operational costs, skilled scientific talent, and strong government support for life sciences innovation, there is rapid growth in the research and development sector of the Asia Pacific region and resultantly, demand for life science instruments is also increasing proportionally.

Browse the full report description of “Asia-Pacific Life Science Instrumentation Market Size, Share & Trends Analysis Report by Technology (Chromatography, Spectroscopy, Polymerase Chain Reaction (PCR), Clinical Chemistry Analyzers, Immunoassays, Next Generation Sequencing (NGS), Flow Cytometry, Microscopy, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, and Hospitals & Laboratories), Forecast Period (2026-2035)” of https://www.omrglobal.com/industry-reports/asia-pacific-life-science-instrumentation-market

For instance, several companies, including Polaris Partners, MPM BioImpact, have opened offices in Singapore due to its scientific capabilities and strategic position to access the broader Asian market. And this growth is driven by tax incentives, favorable government policy and funding programs. The Nucleic Acid Therapeutics Initiative by the Singapore government is a significant example of this, as these research activities include nucleic acid design, synthesis, and delivery system development, for which life science instruments, including PCR and qPCR systems, DNA/RNA sequencers, and chromatography systems are required, among others.

In January 2025, the South Korean government launched the Presidential Bio Committee with the aim of promoting biotechnology research and development in the country. And this is where the role of life science instruments comes into the picture as PCR systems, mass spectrometers and others are essential for modern biotechnology research, which directly led to the demand for life science instruments.

And that’s how pharmaceutical and biotech companies in the region are focusing on investing in advanced R&D capabilities, which require life science instruments to accelerate the drug pipelines and give efficient treatment to the patients.

 Asia-Pacific Life Science Instrumentation Market Boosted by New R&D and Manufacturing Facilities

• December 2025: Thermo Fisher announced the plan to start a new Bioprocess Design Center in Hyderabad, India. Also, they have expanded to support the biologics production through research and commercialization.                                          

• October 2025: Shimadzu Asia Pacific announced plans to establish its first analytical instrument manufacturing facility in Bengaluru, India, with operations expected to begin by 2027. The facility is intended to manufacture mass spectrometers and other analytical instruments, such as liquid chromatography systems, which are widely used in pharmaceutical research, development, and quality control.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
• Technology
• End-Users
• Competitive Landscape – Thermo Fisher Scientific Inc., Agilent Technologies Inc., Shimadzu Corp., Danaher Corp. and PerkinElmer Inc.

 Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Asia-Pacific Life Science Instrumentation Market Report Segment

By Technology

• Chromatography
• Spectroscopy
• Polymerase Chain Reaction (PCR)
• Clinical Chemistry Analyzers
• Immunoassays
• Next Generation Sequencing (NGS)
• Flow Cytometry
• Microscopy
• Others (Centrifuges, Electrophoresis)

By End-Users

• Pharmaceutical & Biotechnology Companies
• Research Institutes
• Hospitals and Laboratories

Asia-Pacific Life Science Instrumentation Market Report Segment by Region

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

 To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-life-science-instrumentation-market